Molecular Templates, Inc.
NASDAQ:MTEM
Overview | Financials
Company Name | Molecular Templates, Inc. |
Symbol | MTEM |
Currency | USD |
Price | 0.457 |
Market Cap | 3,009,492 |
Dividend Yield | 0% |
52-week-range | 0.3 - 6.25 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Eric E. Poma Ph.D. |
Website | https://www.mtem.com |
An error occurred while fetching data.
About Molecular Templates, Inc.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD